Introduction
Wockhardt, India). Dextran (2.5 mL, 6 % (w/v), Sigma) dissolved in 1× balanced salt 1 solution (BSS; 0.13 M NaCl, 2.6 mM KCl, 8.0 mM Na2HPO4, 1.83 mM KH2PO4, pH 2 7.4) was added and mixed by a single inversion. Blood was transferred into a fresh 3 UC and allowed to fractionate for 1 hour. The buffy coat layer (~1.5 mL) was 4 transferred into a fresh UC. Cells were collected by centrifugation (300 g, 2 minutes, 5 room temperature) and the pellet resuspended in sterile H2O to burst any 6 contaminating erythrocyte membranes. After 10 seconds the UC was filled with BSS 7 and the leukocytes were pelleted as above. The pellet was resuspended in Krebs- were incubated on ice, in darkness, with CellTrace TM (1:1000; C34851, Invitrogen).
13
After 10 minutes, leukocytes were centrifuged, resuspended in Krebs-BSA and left to 14 settle on ice for 30 minutes. Prior to the attachment assay, the leukocyte suspension 15 was diluted 1:10 with Krebs-BSA pre-warmed to 37 °C.
16
Leukocyte Attachment Assay 17 Serum-free M199 (150 µL) containing 1.2 ± 0.4 ×10 10 (Control), 2.5 ± 0.4 ×10 10 18 (TNF-α), 8.6 ± 0.8 ×10 10 (Hypoxia) and 1.2 ± 0.3 ×10 11 (TNF-α & Hypoxia) adipocyte 19 EV/mL (mean ± SEM; N=3, n=9), was added to individual wells of a 96-well plate 20 containing a confluent monolayer of HUVECs. Wells were also used to determine 21 basal leukocyte attachment (no EVs; negative control) or 100 ng/mL TNF-α to 22 increase HUVEC VCAM-1 production (no EVs; positive control). After 6 hours, EVs 23 were removed with three Krebs washes before 150 µL of the fluorescently-labelled 24 leukocyte suspension was added to all wells. Plates were incubated for 30 minutes 25 before non-adherent cells were removed with three Krebs washes. Three images 26 from around the centre of each well were captured using an inverted fluorescence 27 microscope. The percentage of total image area covered by leukocytes was 28 determined using Image J software (1.49v; National Institutes of Health, USA). 29 Incubation timings were based on published protocols 20 
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TNF-α Neutralisation Assay 1
A TNF-α neutralising antibody was used to determine whether EVs derived from 2 adipocytes treated with TNF-α, mediated VCAM-1 upregulation in HUVECs. To 3 neutralise any pre-existing TNF-α, HUVECs and adipocyte-derived EVs were 4 incubated separately in serum-free culture medium containing 0, 3, 10, 30, 100 or 5 300 ng/mL TNF-α neutralising antibody. After 2 hours, HUVEC media were removed 6 and the EV-containing media were added to the corresponding wells. After 6 hours, 7 HUVECs were lysed and VCAM-1 levels assessed by Western blotting, as 8 previously described. Four sets of adipocyte-derived EVs were used in this 9 experiment with each set tested on one HUVEC sample (N=4, n=4).
10
Analysis of 3T3-L1 Cell and EV Proteins
11
Adipocyte cell and EV lysates were assessed by Western blotting as previously 
Effect of Adipocyte EVs on Leukocyte-to-Endothelial Cell Attachment 2
HUVECs pre-treated with TNFα+hypoxia-derived adipocyte EVs, increased 3 leukocyte attachment to the same extent as the positive control ( Figure 1A ). These 4 increases were significant when compared to those observed for HUVECs not 5 treated with EVs and HUVECs pre-treated with control adipocyte EVs ( Figure 1A ).
6
Leukocyte attachment was also greater following treatment with TNFα+hypoxia-7 derived EVs compared to hypoxia-derived adipocyte EVs. Pre-treating HUVECs with 8 TNF-α-derived adipocyte EVs also increased leukocyte attachment compared to 9 HUVECs not treated with EVs. No other differences were observed in leukocyte 10 attachment to HUVECs after pre-treatment with adipocyte EVs. Using size-exclusion 11 chromatography, we confirm that TNF-α is associated with EVs; there is no free 12 TNF-α ( Supplementary Figure 1 ). 
13
Effect of Adipocyte EVs on HUVEC Protein Production
Adipokine Production in Adipocytes and Adipocyte-Derived EVs 1
No effect on the production of FABP4 in cell lysates due to any treatment was 2 identified ( Figure 5A ). FABP4 in was increased in EVs lysates of cells treated with 3 TNF-α regardless of normoxia or hypoxia ( Figure 5B ). Adiponectin production was 4 decreased in cells treated with TNF-α+hypoxia compared to that of control cells, but 5 individually, TNF-α and hypoxia had no effect ( Figure 5C ). All treatments appeared 6 to decrease adiponectin in EV lysates compared to that of control cells ( Figure 5D ).
7
PPARγ production in cell lysates decreased in response to hypoxia and TNF-8 α+hypoxia ( Figure 5E ). Conversely, hypoxia-and TNF-α+hypoxia-derived EVs 9 contained more PPARγ ( Figure 5F ). Compared to that of control cells, perilipin 10 production decreased in response to hypoxia and TNF-α+hypoxia ( Figure 5G ). No 11 differences in the production of perilipin in EVs were identified ( Figure 5H ). Figure 6B ).
Discussion
1 Increased adiposity has long been recognised as a risk factor for cardiovascular 2 disease development 1 . In obesity, adipose tissue inflammation is associated with 3 vascular inflammation 21 and one of the primary mediators of this process is the 4 inflammatory cytokine, TNF-α. Whilst TNF-α is secreted by adipocytes themselves, 5 levels in obese adipose tissue are predominantly raised by activated macrophages 22 . 6 TNF-α desensitizes adipocytes to insulin 23 , but distally and in terms of effects on 7 vascular endothelial cells, plasma TNF-α levels positively correlate with adhesion 8 molecule production, disrupted eNOS activity and oxidative stress 24 . We are the first 9 to show that EVs derived from adipocytes residing within a hypoxic and with TNF-α and TNF-α+hypoxia derived adipocyte EVs and mirrored the increase in 31 VCAM-1 detected by Western blotting. We hypothesize that in order to detect subtle 32 changes in surface marker expression between treatment groups will likely require a 33 very high number of HUVEC/experimental replicates and it is acknowledged further 34 studies will be required in order to investigate differences in surface expression.
35
The fact that inflammatory adipocyte EVs increase HUVEC VCAM-1 production, 36 does however, offer a mechanism through which leukocyte-to-endothelial cell 37 attachment is achieved. TNFR1 receptors have been shown to induce VCAM-1 38 mRNA and protein via a pathway mediated by NF-κB but not ERK, p38MAPK or JNK 39 kinase 25 . Future experiments aim to determine if the TNF-α delivered to HUVECs by 3T3-L1 EVs activates TNFR1 receptors and mediates VCAM-1 upregulation via a 1 similar mechanism. As TNF-α neutralisation prevents VCAM-1 upregulation, we 2 hypothesise that this would also prevent the increase in leukocyte-to-endothelial cell 3 attachment following incubation of HUVEC with TNF-α and TNF-α+hypoxia derived 4 adipocyte EVs. In vivo, VCAM-1 is involved in the firm attachment of leukocytes to 5 endothelial cells prior to their transmigration though the vessel wall 26, 27 , and whilst 6 enhanced VCAM-1 production accompanied by leukocyte attachment is known to 7 contribute to the progression of atherosclerosis 28, 29 , we can now suggest that this is 8 at least partly mediated by EVs derived from hypoxic and inflamed adipocytes.
9
In this study, EVs were not processed further to remove possible contaminating 10 "free" TNF-α. However, we do provide evidence that TNF-α co-elutes with CD63 11 and FABP-4 following size exclusion chromatography of EV samples and that no 12 "free" TNF-α elutes in later fractions. This indicates that TNF-α within EV samples is 13 EV-associated ( Supplementary Figure 1) . In addition, it is important to note that the 14 leukocytes for the leukocyte-to-endothelial attachment assay were isolated from in this study can be attributed to 3T3-L1 EVs. It is also important to note that once 20 isolated from blood, the leukocytes were resuspended in 0.22 µm sterile-filtered 21 Krebs-BSA. As such, there is a chance that bovine serum EVs smaller than 0.22 µm 22 were present in this buffer and that they too could have affected leukocyte adhesion. 
26
Our results add to the growing body of literature confirming that adipocytes not only 27 release EVs 15, 16, 32 , but that the information conveyed through their content has a 28 functional effect on other cell types. As such, we investigated the effect of 29 inflammatory and hypoxic stimuli on the production of several proteins (FABP4, 30 adiponectin, PPARɣ and perilipin) linked to cardiovascular disease in both adipocyte 31 cell and EV lysates. We hypothesise that differences in the content of these proteins 32 within EVs derived from inflammatory and/or hypoxic adipocytes may confer 33 mechanistic influences on leukocyte attachment to vascular endothelial cells. Future 34 studies will seek to identify and elucidate such mechanisms.
35
Plasma levels of FABP4, a fatty-acid chaperone protein 33 , have been shown to 36 increase in obesity 34 and are associated with vascular endothelial cell dysfunction 35 . 37 We observed no change in the FABP4 content of adipocyte cell lysates in response 38 to inflammatory or hypoxic stimuli. This result supports a previous study whereby 39 FABP4 production in adipocyte cell lysates was also shown not to change in 40 response to hypoxia 36 . What is interesting, however, is that the authors of this study did identify an increased level of FABP4 in adipocyte culture media in response to this may be because it is released in to the circulation from adipocytes as a free 1 protein rather than being associated with EVs. This hypothesis fits with our results as 2 we identified no difference in the perilipin content of adipocyte EVs in response to 3 inflammatory and hypoxic stimuli.
4
In terms of specific EV character, our group has previously shown that EVs isolated 5 from adipocytes express the vesicular proteins CD9, CD63, Alix, tumour 6 susceptibility gene (TSG101) 16 , and now show that they also exhibit characteristic 7 cup-shape morphology by electron microscopy (Supplementary Figure 1) . Here we 8 show the yield and size of adipocyte-derived EVs can be modulated independently 9 by external stimuli. TNF-α, hypoxia and TNF-α+hypoxia increased the yield of 10 EVs/cell whilst decreasing their size. These physical changes may themselves also 11 confer distinct functional effects. However, it is important to note that the size data 12 presented is based solely on raw NTA values; no refractive index 45 nor mathematical 13 modelling 46 was applied.
14 In summary, we provide evidence that adipocytes residing in a hypoxic and 15 inflammatory environment produce EVs capable of inducing VCAM-1 production in 16 vascular endothelial cells, and that this effect promotes leukocyte attachment. We 17 also show that both inflammatory and hypoxic stimuli not only influence the 18 adipokine content of adipocytes and their EVs, but also effect EV yield and size.
19
Future studies will further explore the functional impact inflammatory and hypoxic Acquisition was terminated upon recording 10,000 events and events gated based 25 on their forward scatter and side scatter characteristics, as we have described in 26 detail previously for HUVEC 1 .
27
Results 1 Size Exclusion Chromatography 2 A peak in particle concentration is observed between fractions 6-8 (Supplementary 3 Figure 1A ). Protein content shows low levels across the 30 fractions (Supplementary 4 Figure 1B) . The protein content is highest in fractions 7 and 8. TNF-α appears in 5 fractions 6-8 which also contain CD63 and FABP4 and does not appear in later 6 fractions where soluble protein would elute (Supplementary Figure 1C ). This 7 provides evidence that a small level of TNF-α is strongly associated with EVs. This 8 also confirms that the majority of soluble TNF-α added to the initial cell culture is 9 removed during washing/centrifugation steps 10 TEM Electron Microscopy 11 3T3-L1 EVs display typical cup-shape morphology ( Supplementary Figure 2) .
A Basal (No EVs) TNFα EVs Control EVs
Hypoxia EVs
TNFα ( 
